WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 341433

CAS#: 13741-18-9

Description: Xibornol is a biochemical.

Chemical Structure

CAS# 13741-18-9

Theoretical Analysis

MedKoo Cat#: 341433
Name: Xibornol
CAS#: 13741-18-9
Chemical Formula: C18H26O
Exact Mass: 258.1984
Molecular Weight: 258.405
Elemental Analysis: C, 83.67; H, 10.14; O, 6.19

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Xibornol; CP-34; CP 34; CP34; Bactacine.

IUPAC/Chemical Name: 3,4-Xylenol, 6-isobornyl- (8CI)


InChi Code: InChI=1S/C18H26O/c1-11-8-14(16(19)9-12(11)2)15-10-13-6-7-18(15,5)17(13,3)4/h8-9,13,15,19H,6-7,10H2,1-5H3


Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 258.405 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Zeh A, Planert M, Klima S, Hein W, Wohlrab D. The flexible Triac-Brace for conservative treatment of idiopathic scoliosis. An alternative treatment option? Acta Orthop Belg. 2008 Aug;74(4):512-21. PubMed PMID: 18811036.

2: Cirri M, Mura P, Mora PC. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. Int J Pharm. 2007 Aug 1;340(1-2):84-91. Epub 2007 Mar 30. PubMed PMID: 17531411.

3: Cairella M. [Active drugs in diseases of the respiratory system]. Clin Ter. 1988 Jul 15;126(1):67-9. Italian. PubMed PMID: 2973962.

4: Fabbri A, Tacchella A, Belli ML. Activity of xibornol against Staphylococcus aureus. Chemioterapia. 1988 Apr;7(2):86-8. PubMed PMID: 3396117.

5: Fraschini F, Scaglione F, Maierna G, Savio G, Gattei G, Falchi M. Non-interference of xibornol on the theophylline blood levels. Int J Clin Pharmacol Res. 1988;8(1):43-6. PubMed PMID: 3366502.

6: Scaglione F, Trazzi R, Odero A, Sambataro G, Savio G, Ferrara F, Fraschini F. Xibornol: multiple dose pharmacokinetics and diffusion in lung, tonsillar tissue and laryngeal mucosa. Int J Clin Pharmacol Res. 1988;8(6):457-61. PubMed PMID: 3253223.

7: Combe J, Simonnet F, Simonnet G. [Action of xibornol on cell division and macromolecular synthesis of gram-positive bacterias]. Ann Pharm Fr. 1988;46(1):19-26. French. PubMed PMID: 3146238.

8: Borzani M, Varotto F, Garlaschi L, Scotti G, Savio G. [Evaluation of the eradicating capacity of xibornol in pediatric pharyngeal carriers of beta-hemolytic streptococci and study of the interaction between the drug and the chemiluminescent activity of PMN leukocytes]. Minerva Pediatr. 1987 Jun 30;39(11-12):555-9. Italian. PubMed PMID: 3627066.

9: De Mattia D, Santoro A, Grumo AR, Santoro N. [Xibornol in inflammatory involvement of the upper airways in childhood. A comparative clinical investigation]. Minerva Pediatr. 1986 Nov 15;38(21):1017-24. Italian. PubMed PMID: 3807837.

10: Capristo AF, Maiello N, Coppola T, Decimo F, Miraglia del Giudice M Jr, Antignani RG. [Clinical evaluation of a new antibacterial agent, xibornol, in the treatment of bacterial infections of the upper respiratory tract in childhood. Comparison with erythromycin]. Minerva Pediatr. 1986 Jun 30;38(11-12):503-10. Italian. PubMed PMID: 3526110.

11: Oggero R, Pugliaro G, Galvagno G, Frigerio M. [Antibacterial efficacy of a new chemotherapeutic agent in acute infections of the upper respiratory tract in childhood. Controlled clinical trial of xibornol and josamycin]. Minerva Pediatr. 1985 May 31;37(10):419-24. Italian. PubMed PMID: 3900675.

12: Morandini G, Finiguerra M, Bagno M. [Efficacy and tolerability of a new chemotherapeutic agent in the treatment of recurrent chronic bronchitis: xibornol]. Clin Ter. 1985 Feb 15;112(3):233-9. Italian. PubMed PMID: 4028638.

13: Olivieri D, Savio G, Del Donno M, Annicelli A, Tranfa CM. [Effects of xibornol on mucociliary clearance in patients with chronic bronchopathy in an acute phase]. Arch Monaldi. 1984 Jul-Aug;39(4):301-6. Italian. PubMed PMID: 6537755.

14: Olivieri D, Savio G, Giacomelli P, Montella R, Del Donno M. [Clinical evaluation of the therapeutic efficacy of xibornol in acute infections in chronic pulmonary diseases (controlled clinical study)]. Arch Monaldi. 1984 Jul-Aug;39(4):289-300. Italian. PubMed PMID: 6399668.

15: Zanon P, De Rose V, Bersani C, Caritinos P, Mazzocchi P. In vivo study of xibornol on phagocyte functions. Chemioterapia. 1984 Jun;3(3):156-8. PubMed PMID: 6529770.

16: Layes Molla A, Donald JF. A comparison of Bracen and co-trimoxazole in the treatment of acute respiratory tract infections in children. J Int Med Res. 1982;10(4):239-43. PubMed PMID: 6981532.

17: Donald JF, Layes Molla A. A comparison of Bracen and penicillin V in the treatment of acute respiratory tract infections in children. J Int Med Res. 1982;10(4):244-9. PubMed PMID: 6811347.

18: Donald JF, Layes Molla A. A comparison of Bracen and ampicillin in the treatment of acute respiratory tract infections in children. J Int Med Res. 1982;10(4):234-8. PubMed PMID: 6749577.